Challenges In Viral Vector Production & Innovative Solutions

By Mike Marciniak, Senior Director, Sales USA & Canada

The adoption of single-use technologies has brought several advantages to the biopharmaceutical industry such as flexibility, cost-effectiveness, and reduced contamination risks. This technology is also helping manufacturers confront the many challenges surrounding viral vector production.

While the safe handling AAV vectors is already difficult at smaller scales, up-scaling viral vector production brings a whole set of additional challenges to bioprocessing. Take a deeper look into some of these challenges, the multi-stage process of viral-vector manufacturing, what is needed to successfully store viral vectors, and more.